In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NeuroNexus Technologies Inc.

Division of Nuvectra Corp.

Latest From NeuroNexus Technologies Inc.

Neuromodulation 2016: Competition Heats Up In Spinal Cord Stim Market

In the $3.2 billion market for neuromodulation devices, competition is heating up in the spinal cord stimulation (SCS) segment as device manufacturers armed with new clinical trial data and next-generation technologies disrupt the status quo of standard tonic SCS systems and begin to expand the market, shift market share and boost the revenues of companies both large and small. Innovation is fueling healthy growth in this market, particularly in the US, where the market is projected to grow from around $1.13 billion in 2014 to almost $1.62 billion in 2019, a CAGR of 7.5%.

Medical Device Innovation

New Medical Device R&D Center In Singapore To Focus On Designs At “Disruptive” Price Point – Greatbatch

U.S.-listed Greatbatch Inc. opens the first medical device R&D center in Singapore, pinning hopes on the country’s growing biomedical community for talent, industry contacts and possibly manufacturing, the company’s chief technology officer says.

Medical Device Singapore

Deep Brain Provides Stimulating Market

There are signs that the field of deep brain stimulation (DBS) has gained a certain momentum of late: three start-ups raised venture rounds in 2011 and there have been two acquisitions in the space within the past year. DBS enables the giants in cardiac rhythm management – Medtronic, St. Jude Medical, and Boston Scientific –to leverage existing technology platforms from CRM to address a new area once served primarily by drugs, and start-ups can help them by validating new disease targets and increasing procedural accuracy and efficiency. The space is appealing because with a single platform, companies can address several diseases with large populations, such as depression and Alzheimer’s disease. But the opportunities remain far from certain with this highly complex technology.

Medical Device

Medical Device Deals Update, March 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nuvectra Corp.
  • Senior Management
  • Daryl Kipke, PhD, Pres. & CEO
    Kc Kong, Dir., Sales & Mktg.
    Linda Thompson, Dir., Fin. & Admin.
  • Contact Info
  • NeuroNexus Technologies Inc.
    Phone: (734) 913-8858
    655 Fairfield Ct.
    Ste. 100
    Ann Arbor, MI 48108